These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Nicotine-replacement therapy with use of a transdermal nicotine patch--a randomized double-blind placebo-controlled trial. Hurt RD, Lauger GG, Offord KP, Kottke TE, Dale LC. Mayo Clin Proc; 1990 Dec; 65(12):1529-37. PubMed ID: 2255215 [Abstract] [Full Text] [Related]
25. [Smoking cessation with the nicotine patch]. Batra A, Buchkremer G. Z Arztl Fortbild (Jena); 1995 Oct; 89(5):505-9. PubMed ID: 8578778 [Abstract] [Full Text] [Related]
26. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA. Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [Abstract] [Full Text] [Related]
29. Behavioral relapse prevention strategies in smoking cessation. Minneker-Hügel E, Unland H, Buchkremer G. Int J Addict; 1992 May; 27(5):627-34. PubMed ID: 1601540 [Abstract] [Full Text] [Related]
30. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial. Foulds J, Stapleton J, Hayward M, Russell MA, Feyerabend C, Fleming T, Costello J. Arch Fam Med; 1993 Apr; 2(4):417-23. PubMed ID: 8130921 [Abstract] [Full Text] [Related]
31. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. JAMA; 1995 Nov 01; 274(17):1353-8. PubMed ID: 7563559 [Abstract] [Full Text] [Related]
32. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers. Sørensen LT, Jorgensen LN, Zillmer R, Vange J, Hemmingsen U, Gottrup F. Wound Repair Regen; 2006 Nov 01; 14(3):247-51. PubMed ID: 16808802 [Abstract] [Full Text] [Related]
33. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Arch Fam Med; 1998 Nov 01; 7(6):569-74. PubMed ID: 9821833 [Abstract] [Full Text] [Related]
34. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Richmond RL, Kehoe L, de Almeida Neto AC. Heart; 1997 Dec 01; 78(6):617-8. PubMed ID: 9470884 [Abstract] [Full Text] [Related]
37. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. Orleans CT, Resch N, Noll E, Keintz MK, Rimer BK, Brown TV, Snedden TM. JAMA; 1994 Feb 23; 271(8):601-7. PubMed ID: 8301792 [Abstract] [Full Text] [Related]